Baricitinib rapidly and sustainably relieves a patient from chronic pruritus of unknown origin refractory to dupilumab

Bibliographic Details
Main Authors: Thomas Buttgereit, MD, Eva Maria Grekowitz, MD, Martin Metz, MD
Format: Article
Language:English
Published: Elsevier 2021-09-01
Series:JAAD Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352512621004689